FdaApplication

BLA 761139

Back to search

Identifiers

Properties

PropertyValue
applicant_nameDaiichi Sankyo, Inc
application_typeBLA
approval_date2019-12-20

Products (1)

ProductActive ingredientStrengthDosage form
ENHERTUFAM-TRASTUZUMAB DERUXTECAN-NXKI100MGFor Injection

1 product